FDA Adverse Event Injury Summary report: N

PULSE GEN MODEL 103

MDR report key: 2761290 · Received September 26, 2012

Report

Report Number
1644487-2012-02445
Event Type
Injury
Date Received
September 26, 2012
Date of Event
August 15, 2012
Report Date
August 28, 2012
Manufacturer
CYBERONICS, INC.
Product Code
LYJ
PMA / PMN Number
P970003
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

BRAND NAME, MODEL #, SERIAL #, LOT #, EXPIRATION DATE, MANUFACTURE DATE: CORRECTED DATA: PREVIOUSLY SUBMITTED MDR OMITTED PRODUCT INFORMATION. ADDITIONAL INFORMATION WAS PROVIDED WITH THE IMPLANTED PRODUCT INFORMATION. THIS REPORT IS BEING SENT TO CORRECT THIS INFORMATION. OPERATOR OF DEVICE, CORRECTED DATA: PREVIOUSLY SUBMITTED MDR INDICATED THE PATIENT WAS THE OPERATOR OF DEVICE; HOWEVER, AS THE PARALYSIS LIKELY RESULTED FROM SURGERY, THE HEATH PROFESSIONAL IS THE OPERATOR OF THE DEVICE. THIS REPORT IS BEING SENT TO CORRECT THIS INFORMATION.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED ON (B)(4) 2012. THE PARALYSIS WAS NOT OCCURRING WITH STIMULATION. THE PATIENT WAS EVALUATED BY AN ENT AND WAS DIAGNOSED WITH AN IMMOBILE LEFT VOCAL CORD. THE PATIENT'S OUTPUT CURRENT WAS 0.25 MA. NO INTERVENTIONS WERE TAKEN, AND THE PATIENT DID NOT HAVE A HISTORY OF VOCAL CORD PARALYSIS.

Description of Event or Problem · 1

ON (B)(6) 2012, IT WAS REPORTED THAT THIS VNS PATIENT WAS BELIEVED TO HAVE VOCAL CORD PARALYSIS. THE PATIENT HAD ALWAYS HAD A SOFTER VOICE, BUT HIS VOICE APPEARED TO BE EVEN SOFTER EVER SINCE IMPLANT. THE DEVICE WAS PROGRAMMED OFF AFTER IMPLANT ON 08/15/2012. THE PATIENT WAS SEEN ON (B)(6) 2012 AND THE DEVICE WAS PROGRAMMED ON. THE PATIENT WAS REFERRED BACK TO THE SURGEON. ATTEMPTS FOR ADDITIONAL INFORMATION HAVE BEEN UNSUCCESSFUL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PULSE GEN MODEL 103 GENERATOR LYJ CYBERONICS, INC. 103 202150

Patients

Seq Age Sex Outcome Treatment
1 21 YR Other